Liminatus Pharma LLC(LIMN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LIMN Liminatus Pharma LLC

Market Closed 06-05 16:00:00 EDT

0.1422

-0.0090

-5.95%

盘后0.1401

-0.0021-1.48%

19:58 EDT

High0.1548	Low0.1359	Vol2.80M
Open0.1512	D1 Closing0.1512	Amplitude12.50%
Mkt Cap6.38M	Tradable Cap1.36M	Total Shares44.88M
T/O403.72K	T/O Rate29.32%	Tradable Shares9.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LIMN","market":"US","secType":"STK","nameCN":"Liminatus Pharma LLC","latestPrice":0.1422,"timestamp":1780689600000,"preClose":0.1512,"halted":0,"volume":2801481,"hourTrading":{"tag":"盘后","latestPrice":0.1401,"preClose":0.1422,"latestTime":"19:58 EDT","volume":67185,"amount":9520.7,"timestamp":1780703909417,"change":-0.0021,"changeRate":-0.014768,"amplitude":0.070323},"delay":0,"changeRate":-0.059523809523809576,"floatShares":9555200,"shares":44877600,"eps":-0.387713,"marketStatus":"Market Closed","change":-0.009,"latestTime":"06-05 16:00:00 EDT","open":0.1512,"high":0.1548,"low":0.1359,"amount":403716.32821458,"amplitude":0.125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.387713,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1512,"preHourTrading":{"tag":"盘前","latestPrice":0.1535,"preClose":0.1512,"latestTime":"09:25 EDT","volume":121788,"amount":18257.26830912,"timestamp":1780665938782,"change":0.0023,"changeRate":0.015212,"amplitude":0.055556},"postHourTrading":{"tag":"盘后","latestPrice":0.1401,"preClose":0.1422,"latestTime":"19:58 EDT","volume":67185,"amount":9520.7,"timestamp":1780703909417,"change":-0.0021,"changeRate":-0.014768,"amplitude":0.070323},"volumeRatio":0.4167313498520789},"requestUrl":"/m/hq/s/LIMN/tweets","defaultTab":"tweets","newsList":[{"id":"2640904687","title":"Liminatus Pharma issues new warrants for 20,688,000 shares in inducement deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904687","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904687?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:34","pubTimestamp":1780490044,"startTime":"0","endTime":"0","summary":"Liminatus Pharma entered a warrant exercise agreement covering 10,344,000 shares, cutting the exercise price to USD 0.18.Cash exercise expected to generate USD 1.9 million in gross proceeds before fees and expenses.Issuing new unregistered warrants for 20,688,000 shares at USD 0.18, exercisable only after required Nasdaq stockholder approval.New warrants set to expire five years after stockholder approval.Company plans to file an SEC registration statement for resale of shares issuable upon exercise of the new warrants.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDLbYVKZp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4139","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LIMN","IE00BKPKM429.USD","NDAQ","SG9999014039.USD","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","BK4585","SG9999014021.USD","LU2210149790.SGD","IE00BN0W2W23.USD","BK4588","BK4112","SG9999014005.SGD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904560","title":"Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904560","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904560?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:31","pubTimestamp":1780489885,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638361056","title":"Liminatus Pharma appeals Nasdaq delisting notice after missing $50 million market value rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2638361056","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638361056?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:35","pubTimestamp":1779914114,"startTime":"0","endTime":"0","summary":"Liminatus Pharma faces Nasdaq delisting risk for failing to meet $50 million MVLS and $15 million MVPHS continued-listing thresholds.Nasdaq issued a noncompliance notice on May 20, 2026; trading suspension was set for May 29, 2026 absent an appeal by May 27.An appeal request filed May 26, 2026 triggers a stay, pausing any suspension or delisting pending a Nasdaq Hearings Panel decision.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL3vxd3d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637707318","title":"Liminatus Pharma receives Nasdaq delisting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2637707318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637707318?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:50","pubTimestamp":1779443447,"startTime":"0","endTime":"0","summary":"Liminatus Pharma (LIMN) announced that the company received a delisting notice from The Nasdaq Stock Market. On May 20, the company received a noti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-receives-nasdaq-delisting-notice-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-receives-nasdaq-delisting-notice-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365533","title":"Liminatus Pharma appeals Nasdaq delisting notice, trading suspension set May 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365533","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365533?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:28","pubTimestamp":1779409718,"startTime":"0","endTime":"0","summary":"Liminatus Pharma received a Nasdaq delisting notice on May 20, 2026, tied to failures to meet minimum market value thresholds for listed securities and publicly held shares.Trading in the common stock and warrants is set to be suspended at the open on May 29, 2026, unless an appeal is requested by May 27, 2026.An appeal request would pause the suspension and delisting process while the matter is reviewed by a Nasdaq hearings panel.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL1BPKNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4139","BK4112","SG9999014039.USD","SG9999014021.USD","IE00B64PRP62.GBP","NDAQ","IE00BN0W2W23.USD","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","LIMN","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365538","title":"Liminatus Pharma Announces Nasdaq Delisting Notification","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365538","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365538?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:28","pubTimestamp":1779409706,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUA9PFH7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637067357","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2637067357","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637067357?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:43","pubTimestamp":1779399780,"startTime":"0","endTime":"0","summary":"American Airlines Group      AAL   108,585,692     13.59     0.64      4.94. Direxion TSLA Bull 2X       TSLL    74,381,609     14.72     0.05      0.34. ProShares UltraPro QQQ      TQQQ    73,481,306     76.95     0.44      0.58. GrShr 2x Sh NVDA Daily       NVD    69,568,217      4.53     0.14      3.19. ProSh UltraPro Shrt QQQ     SQQQ    59,610,117     41.96    -0.23     -0.55. Direxion PLTR Bear 1X       PLTD    41,120,749      7.83    -0.01     -0.14. Defiance Tgt 2x Shrt IONQ   IONZ    40,170,425      2.88    -0.96    -25.00. Leverage 2X Lg TSLA Dly     TSLG    38,851,439      7.24     0.01      0.14. Defiance Tgt 2x Shrt RGTI   RGTZ    37,738,323      4.79    -7.46    -60.90","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLL","HK0000320264.USD","LU2462591277.SGD","LU2756315664.SGD","LU2322448791.USD","IE00B19Z9505.USD","LU1116320901.HKD","LU1934455194.USD","IE00BZ1G4Q59.USD","LU0823434740.USD","LU2471134523.USD","LU2360107168.USD","LU0354030438.USD","LU2244417387.USD","IE00BZ199S13.USD","LU0265550359.USD","RGTZ","2NVD.UK","LU0689472784.USD","IE00BKVL7J92.USD","LU0320765059.SGD","LU0965508806.USD","SG9999014906.USD","IE00B4YYXB79.USD","LU0070217475.USD","PLTD","SG9999001424.SGD","TSL","BK4614","LU0823414478.USD","NVDL","LU0390134368.USD","LU2357125470.USD","LU0820562030.AUD","NVYY","LU0096364046.USD","LU2168564065.EUR","IE000W1ABFV2.USD","TSLT","BK4511","LU1323610961.USD","IE00BDRTCR15.USD","TSLR","LU0276348264.USD","LU0353189680.USD","LU2552382132.HKD","SG9999017495.SGD","LU1983260115.SGD","IE00BHPRN162.USD","LU0053666078.USD","LU1670756490.USD","LU1803068979.SGD","SG9999014914.USD","IE00B19Z8X17.USD","LU0859254822.USD","LU1935043536.SGD","LU2452424414.USD","LU0965509010.AUD","NDX","LU2931357623.SGD","TSLI","LU0109392836.USD","LU0069063385.USD","BK4554","IE0009356076.USD","LU2272731600.USD","AALG","LU0056508442.USD","IE00BK4W5M84.HKD","LU1861215975.USD","NVDY","LU2087625088.SGD","NVDW","LU1951198990.SGD","BK4604","LU1633808545.USD","LU0082616367.USD","IE00BQXX3D17.EUR","LU1861127337.USD","TSLO","LU0081259029.USD","LU1815333072.USD","LU1429558221.USD","LU2543165471.USD","LU2430703178.SGD","LU1917777945.USD","RGTI","LU2089283258.USD","LU0133085943.USD","NVII","LU2265009873.SGD","IE00B3SWFQ91.USD","LU0823434583.USD","LU1244550577.SGD","LU1037948897.HKD","LU0174119429.USD","LU0308772762.SGD","LU0823421416.USD","LU2403377893.USD","LU0158827781.USD","LU0466842654.USD","HK0000320223.HKD","LU2125154935.USD","NVDB","BK4592","SG9999015952.SGD","TSLW","WMT","07766","SG9999015358.SGD","LU2999663052.SGD","LU1316542783.SGD","LU0097036916.USD","LU1244550221.USD","GB00BDT5M118.USD","LU2505996509.AUD","LU2430703251.USD","LU1868836591.USD","BK4566","NVDU","LU2087621335.USD","IONZ","LU2896262040.SGD","NVDS","LU0077335932.USD","SG9999015978.USD","LU1935042215.USD","HK0000914660.USD","LU0096362180.USD","LU2023250330.USD","LU2381873111.SGD","NVDO","LU0787776722.HKD","INTC","TSII","LU0417517546.SGD","LU2430703095.HKD","LU0476273544.USD","LU1066051811.HKD","BK4598","LU1718418525.SGD","IE0004445239.USD","LU2092627202.USD","LU2394011477.USD","MU","SG9999014542.SGD","TSLG","LU1084165304.USD","LU2506951792.HKD","SG9999014898.SGD","AAPL","LU0215105999.USD","LU2271345857.HKD","LU0786609619.USD","BK4534","IE00BFSS7M15.SGD","LU0354030511.USD","TSLQ","LU0251132253.USD","LU2750360641.GBP","KEEL","LU0267386448.USD","BK4515","SG9999002224.SGD","IE00BN29S564.USD","LU2456880835.USD","LU0889565833.HKD","LU2065171402.SGD","LU0820561818.USD","LU0557290698.USD","LU0265550946.USD","LU2097344431.USD","IE00BQXX3F31.USD","LU2125909759.SGD","LU2125909593.SGD","IE0009G5SDU7.USD","LU1069344957.HKD","NVDD","SQQQ","IE00BMPRXR70.SGD","LU2125909247.SGD","IE0034235295.USD","IE00BWXC8680.SGD","LU2361044865.SGD","SG9999014567.USD","LU2023251221.USD","LU1623119135.USD","LU0211328371.USD","LU0048584097.USD","LU2242649171.HKD","BK4612","LU2089985449.USD","LU2028103732.USD","NVD3.UK","SGXZ51526630.SGD","LU0823421333.USD","BK4587","09766","07788","LU0210528500.USD","LU0345770308.USD","SG9999018857.SGD","IE00B4JS1V06.HKD","LU2191332357.HKD","NVDS.UK","IE00B775SV38.USD","LU0154236417.USD","LU1064131342.USD","LU2249611893.SGD","LU2552382058.USD","LU0289961442.SGD","LU1791710400.SGD","LU2491050071.SGD","IE0004091025.USD","LU2237957902.USD","LU1366192091.USD","SOFI","LU0708995401.HKD","IE0004445015.USD","LU2458330243.SGD","LU2471134952.CNY","TLA","LU2360032135.SGD","LU1629891620.HKD","LU0143551892.USD","LU0868494708.USD","LU1923622291.USD","IE00BSNM7G36.USD","LU0109391861.USD","LU0353189763.USD","LU0719512351.SGD","LU2954938101.SGD","LU1366333091.USD","IE00BJLML261.HKD","LU2089284900.SGD","SGXZ23171101.USD","APLD","LU0256863811.USD","LU0289960550.SGD","LU2290526834.HKD","LU0080751232.USD","LU2168564222.USD","BK4588","BK4608","LU0210533765.USD","LU0820561909.HKD","LU0061474705.USD","BK4527","LU0957791311.USD","LU0029864427.USD","LU1861220033.SGD","LU1202635105.USD","SG9999002232.USD","LU0238689110.USD","IE0002270589.USD","LU1066051225.USD","LU2413666699.HKD","IE000KEQY171.SGD","BK4099","BK4535","TSYY","LU0256863902.USD","LU2764263039.SGD","LU2860962120.EUR","SG9999018865.SGD","SG9999000418.SGD","IE00B3M56506.USD","LU1691799644.USD","HK0000914686.HKD","LU0061474960.USD","BK4550","BK4553","LU0342679015.USD","MULL","LU0347712357.USD","BK4532","IE0005OL40V9.USD","BK4008","LU0274383776.USD","NVD","LU2108987350.USD","IE00BK4W5L77.USD","LU0942090050.USD","04335","BK4555","LU1720051108.HKD","LU2023250504.SGD","LU1551013425.SGD","LU0689626769.HKD","LU2264538146.SGD","HK0000306701.USD","LU0079474960.USD","LU2764262908.HKD","BK4575","LU2242650005.HKD","LU0444971666.USD","BK4551","LU2048586759.USD","IE00B19Z3581.USD","DIPS","LU2326559502.SGD","LU1551013342.USD","LU0345769631.USD","LU0345768153.USD","LU1934455277.USD","NVDG","IE00BKDWB100.SGD","LU1145028129.USD","LU1035775433.USD","LU2125154778.USD","LU0203201768.USD","3NVD.UK","LU1989772923.USD","HK0000532082.HKD","LU1232071149.USD","LU0672654240.SGD","LU0106261372.USD","TSLA","BK4500","LU0345769128.USD","BK4529","LU0788109477.HKD","NVD2.UK","IE000YTNTUN2.SGD","TSLS","LU2552382215.SGD","LU0128525929.USD","LU0965509283.SGD","IE00BJJMRY28.SGD","LU3102509885.SGD","LU0107464264.USD","LU1261432733.SGD","LU1804176565.USD","LU1815336760.USD","LU1935042488.USD","IE00B3S45H60.SGD","LU0127658192.USD","ANV","LU1066051498.USD","CRSH","INTW","LU0061475181.USD","LU1989764748.USD","LU2097344357.USD","LIMN","LU2433249047.HKD","LU2602419157.SGD","LU2491050154.USD","LU1988902786.USD","LU0203202063.USD","NVDX","LU2148611432.USD","LU2272731865.HKD","LU0289739343.SGD","LU2764263203.CNY","LU2272731782.SGD","LU1435385759.SGD","SG9999015341.SGD","LU0210536198.USD","LU1153585028.USD","LU1037948541.HKD","LU0225283273.USD","LU2461242641.AUD","LU1852331112.SGD","MUD","IE00BMPRXQ63.HKD","LU1496350502.SGD","IE00BJTD4N35.SGD","IE00BQXX3C00.GBP","LU0170899867.USD","BK4548","IE00BDCRKT87.USD","BK4503","LU0965509101.SGD","HK0000304797.USD","LU1267930813.SGD","SG9999014575.USD","LU0187121727.USD","LU0094547139.USD","IONQ","LU0234572021.USD","NVDQ","LU0889566641.SGD","LU0158827948.USD","LU1721428933.USD","LU0011850046.USD","LU0072462426.USD","SG9999015986.USD","07366","BK4516","LU0683600562.USD","LU1868836914.USD","LU2322448957.HKD","LU2413666426.HKD","LU2756315318.SGD","IE00B1XK9C88.USD","LU1066053197.SGD","LU1242518857.USD","IE00B1BXHZ80.USD","LU0006306889.USD","LU1951200564.SGD","LU0444973449.USD","LU0964807845.USD","LU0882574139.USD","LU0985320562.USD","IE000ITXATA3.USD","BK4585","LU0321505439.SGD","HK0000306685.HKD","IE00B5949003.HKD","LU1814569148.SGD","LU2746668461.USD","LU0823414551.USD","LU2111349929.HKD","LU1548497426.USD","LU2237438978.USD","LU2420271590.USD","SGXZ99366536.SGD","HK0000819398.USD","LU0494093205.USD","LU0642271901.SGD","LU1974910355.USD","LU0310800379.SGD","LU1242518931.SGD","SG9999004303.SGD","AAL","LU1989764664.SGD","LU0198837287.USD","TSLP","SG9999015945.SGD","IE00BKPKM429.USD","LU2458330169.SGD","LU2211815571.USD","LU0472753341.HKD","LU1267930573.SGD","SNVD.UK","LU2286300806.USD","LU0203347892.USD","LU1821325948.USD","LU2462157665.USD","LU1935042991.SGD","BK4512","LU2361044949.HKD","LU2746668974.SGD","IE00B775H168.HKD","LU1989772840.SGD","LU2077746001.SGD","LU2083900584.USD","TSDD","TESL","BK4543","IE000M9KFDE8.USD","LU1119994496.HKD","LU0345770993.USD","SG9999014559.SGD","LU2063271972.USD","IE0034235188.USD","LU2471134796.USD","LINT","IE0004086264.USD","LU1861558580.USD","LU2505996681.GBP","LU0724617625.USD","TEST","LU0316494557.USD","IE00B19Z3B42.SGD","LU1674673691.USD","LU1712237335.SGD","BK4574","IE00BJTD4V19.USD","LU2294711713.HKD","LU2417539215.USD","BK4602","LU0943347566.SGD","LU1571399168.USD","LU0175139822.USD","LU2125909916.SGD","LU2247934214.USD","LU0157215616.USD","LU2361045086.USD","LU1868836757.USD","LU1992135399.USD","LU1127390331.HKD","IE0001KFT4U8.USD","LU0861579265.USD","LU0511384066.AUD","LU0203345920.USD","BK4547","LU0708994859.HKD","LU0823411888.USD","LU1861559042.SGD","09366","LU0348723411.USD","LU2487616109.SGD","LU2168564149.EUR","LU2592432038.USD","LU2065171311.SGD","LU1400636574.HKD","BK4549","LU2357305700.SGD","LU0211327993.USD","BK4581","LU1400636491.USD","LU2491049909.HKD","LU1642822529.SGD","07388","LU2357627491.SGD","LU1699723380.USD","LU1923623000.USD","LU2236285917.USD","IE00BD6J9T35.USD","LU0979878070.USD","LU2065169927.USD","HK0000304805.HKD","LU1720051017.SGD","LU1868837136.USD","LU2637965513.SGD","TQQQ","LU2065170008.USD","IE00B7KXQ091.USD","LU1674673428.USD","LU1935043023.USD","LU2720916845.USD","IREN","LU0057025933.USD","LU0310799852.SGD","LU0528227936.USD","LU1868837300.USD","LU0234570918.USD","LU2100268510.USD","NVDA","LU0266013472.USD","IE00B7SZLL34.SGD","LU1116320737.USD","LU1923622614.USD","LU2471134879.HKD","LU1934455863.HKD","SG9999014880.SGD","LU1778281490.HKD","MUU","SGXZ31699556.SGD","LU2106854487.HKD","IE0003U64NQ7.SGD","LU2168563687.JPY","LU0323591593.USD","LU1267930490.SGD","LU2250418816.HKD","LU0321505868.SGD","LU1645745479.HKD","BK4533","BK4605","IE00BYXW3230.USD","IE00BJJMRX11.SGD","LU2213496289.HKD","IE00B19Z8W00.USD","LU0957808578.USD","LU1244550494.USD","LU1400636657.SGD","TSLZ","LU1496350171.SGD","LU0792757196.USD","LU2462591350.SGD","BK4141","LU1839511570.USD","NVIW.SI","LU0124676726.USD","LU2054465674.USD","BK4567","LU1914381329.SGD","LU2092937148.SGD","LU1267930730.SGD","LU1791710582.SGD","LU0345768740.USD","LU2473716301.USD","LU2047632596.USD","LU0868494617.USD","IE0034235303.USD","LU2168564495.EUR","LU2750360997.AUD","IE00BMPRXN33.USD","LU1280957306.USD","SGXZ81514606.USD","TSLY","BK4579","LU2463028550.USD","LU2360106780.USD","PLTR","LU1992135472.HKD","LU2237957811.SGD","IE00BFSS8Q28.SGD","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333002","title":"Liminatus Pharma agrees to merge with InnocsAI in $320 million stock deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333002","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333002?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:07","pubTimestamp":1779365276,"startTime":"0","endTime":"0","summary":"Liminatus Pharma entered a definitive merger agreement dated May 17, 2026, to combine with InnocsAI, a biotech focused on CAR-T and antibody-based oncology therapies.InnocsAI is set to merge into a newly formed Liminatus Delaware subsidiary, leaving the subsidiary as a wholly owned unit of Liminatus.InnocsAI members are slated to receive 1,600,000,000 shares of Liminatus common stock priced at $0.2 per share, implying a transaction value of about $320 million.The consideration also includes contingent value rights tied to 20% of future net proceeds from certain strategic transactions involving the acquired assets.The deal is intended to expand Liminatus’ oncology pipeline, led by CAR-T programs including IBC101 for relapsed or refractory B-cell malignancies and INC101 for solid tumors.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL6DQTxf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","NDAQ","IE00BN0W2T93.GBP","BK4139","IE00BGHQF748.EUR","BK4588","BK4112","SG9999014005.SGD","LU0314104364.USD","LIMN","BK4585","LU2210150020.SGD","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014021.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333790","title":"Liminatus Pharma Inc - Innocsai Members to Receive 20% of Future Net Proceeds From Certain Strategic Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333790?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:04","pubTimestamp":1779365040,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA53TK3Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637272333","title":"Liminatus Pharma Announces Proposed Merger With Innocsai to Expand Oncology Cell Therapy Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2637272333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637272333?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:04","pubTimestamp":1779365040,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA53TK3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637038042","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637038042","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637038042?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:08","pubTimestamp":1779361719,"startTime":"0","endTime":"0","summary":"Wheeler Real Estate Investment Trust  shares were up 80% in Thursday premarket activity following a nearly 2% fall in the previous session.Liminatus Pharma  stock was 50% higher after the company agreed to merge with InnocsAI.Agape ATP  shares were up 43% after a 3.2% loss in the previous session.Co-Diagnostics  stock was 36% higher after the company announced a $3 million private placement, extending Wednesday's 21% rally.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","ATPC","BK4175","LIMN","BK4568","WHLR","BK4080","BK4139","BK4082","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637875492","title":"Liminatus Pharma Inc - Enters Merger Agreement With Innocsai Llc on May 17, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637875492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637875492?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:04","pubTimestamp":1779311052,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nFWN41X0Z9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637754908","title":"Liminatus Pharma Inc - Innocsai Members to Receive 1.6 Bln Shares at $0.20 per Share and 20% Contingent Value Rights - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637754908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637754908?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:04","pubTimestamp":1779311052,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nFWN41X0Z9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637875485","title":"Liminatus Pharma agrees to buy InnocsAI in 1,600,000,000-share deal at $0.2 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2637875485","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637875485?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:01","pubTimestamp":1779310894,"startTime":"0","endTime":"0","summary":"Liminatus Pharma entered a merger agreement on May 17, 2026 to acquire InnocsAI through a merger into a newly formed wholly owned subsidiary.InnocsAI members are set to receive 1,600,000,000 shares of Liminatus common stock priced at USD 0.2 per share.The deal also includes contingent value rights tied to 20% of net proceeds from any future strategic sale, out-licensing, transfer, or exit of the acquired InnocsAI assets.The acquired portfolio centers on oncology biologic and cellular therapy programs, including a CD19xCD22 CAR-T candidate in Phase 1/2a authorization in South Korea for relapsed or refractory diffuse large B-cell lymphoma.Valetudo Therapeutics, an InnocsAI member, is controlled by Liminatus CEO and director Chris Kim.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interprete","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL935F5N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635005859","title":"Liminatus Pharma Q1 FY26 net loss widens to $1.12 million; operating loss widens 317% to $1.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635005859","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635005859?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:53","pubTimestamp":1778878399,"startTime":"0","endTime":"0","summary":"Liminatus Pharma reported a net loss of $1.12 million for the three months ended March 31, 2026, widening 243% year over year.Operating loss widened to $1.1 million, driven by total operating expenses of $1.1 million, up 317%.General and administrative expense climbed to $700,898, up 165%, while research and development expense was $400,000 versus no such costs a year earlier.Cash totaled $1.91 million at March 31, 2026; net cash used in operating activities increased to $2.02 million from $159,393.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL6r4hST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627253673","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2627253673","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627253673?lang=en_us&edition=fundamental","pubTime":"2026-04-16 05:43","pubTimestamp":1776289380,"startTime":"0","endTime":"0","summary":"Direxion TSLA Bull 2X       TSLL   164,949,242     13.30     1.76     15.25. GrShr 2x Sh NVDA Daily       NVD   106,280,365      5.77    -0.14     -2.37. ProShares UltraPro QQQ      TQQQ    81,656,214     55.65     2.24      4.19. Leverage 2X Lg TSLA Dly     TSLG    79,255,504      6.56     0.88     15.49. American Airlines Group      AAL    58,666,228     12.17     0.04      0.33. Leverage 2X Lg BMNR Dly     BMNG    55,765,097      1.52     0.10      7.04. ProSh UltraPro Shrt QQQ     SQQQ    55,447,821     59.44    -2.58     -4.16. Direxion PLTR Bear 1X       PLTD    54,912,798      7.65    -0.37     -4.61. Invesco QQQ Trust I          QQQ    49,709,649    637.40     8.80      1.40","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0787776722.HKD","LU0082616367.USD","IE0009356076.USD","LU0234570918.USD","IE00B775H168.HKD","IE00B19Z8W00.USD","BK4230","LU0133085943.USD","SNVD.UK","LU1923622291.USD","LU2047632596.USD","LU2168564222.USD","TSII","LU1718418525.SGD","LU2028103732.USD","IE00BQXX3D17.EUR","LU1551013342.USD","LU1803068979.SGD","LU2168563687.JPY","LU2265009873.SGD","LU1316542783.SGD","SG9999018857.SGD","IE0004091025.USD","LU2360106780.USD","LU0788109477.HKD","IE0034235188.USD","LU0708994859.HKD","LU2237957811.SGD","LU2552382058.USD","BK4500","LU0820561818.USD","LU0345768153.USD","LU1989772923.USD","LU0943347566.SGD","LU0557290698.USD","INTC","NVDS.UK","LU2543165471.USD","LU1951200564.SGD","LU0323591593.USD","LU2452424414.USD","BK4575","LU1242518931.SGD","LU2362541513.USD","LU0210528500.USD","LU0642271901.SGD","BK4567","BK4592","LU2125154935.USD","SG9999014567.USD","LU0672654240.SGD","LU1127390331.HKD","LU0528227936.USD","BK4533","BK4579","LU0077335932.USD","SG9999014898.SGD","LU2108987350.USD","LU2092627202.USD","IE00BJTD4N35.SGD","LU0157215616.USD","LU0127658192.USD","IE000KEQY171.SGD","LU2430703178.SGD","IE00B19Z8X17.USD","SG9999001135.SGD","NVDS","INTW","LU1974910355.USD","NVDY","TSLA","LU0124676726.USD","LU1861215975.USD","LU0494093205.USD","LU1202635105.USD","LU2100268510.USD","LU2506951792.HKD","BK4587","LU0210637038.USD","LU1623119135.USD","LU2750360641.GBP","NVD2.UK","LU2125909759.SGD","LU2168564495.EUR","LU1989764748.USD","LU1153585028.USD","HK0000914686.HKD","LU1778281490.HKD","LU0310799852.SGD","BK4008","LU2286300806.USD","LU0061474705.USD","SG9999002679.SGD","SG9999015358.SGD","LU0061475181.USD","BK4585","LU2250418816.HKD","LINT","IE00BFSS8Q28.SGD","NVDX","LU2249611893.SGD","IE000YTNTUN2.SGD","SG9999015952.SGD","LU2491050071.SGD","LU0823414478.USD","LU0274383776.USD","LU0048584097.USD","LU2092937148.SGD","LU1983260115.SGD","ROBN","BK4535","LU0081259029.USD","LU1035775433.USD","LU0965508806.USD","LU1934455194.USD","LU0345769128.USD","LU2746668974.SGD","LU1267930573.SGD","NDX","NVDB","GRAB","LU1069344957.HKD","TECL","LU1923623000.USD","LU2999663052.SGD","TSL","IE00BDRTCR15.USD","HOOG","IE0005OL40V9.USD","LU2362540622.SGD","LU0345768740.USD","HOOW","IE00B4JS1V06.HKD","HK0000306701.USD","LU1145028129.USD","LU2361045086.USD","LU1923622614.USD","SQQQ","LU0979878070.USD","SG9999002232.USD","LU0342679015.USD","IE00BWXC8680.SGD","LU1551013425.SGD","LU1323610961.USD","NVIW.SI","IE00B3S45H60.SGD","LU1267930730.SGD","LU1989772840.SGD","LU2602419157.SGD","LU1861559042.SGD","DIPS","TSLT","AAPL","LU1548497426.USD","HOOX","LU1242518857.USD","LU0417517546.SGD","NVD3.UK","BK4515","LU0266013472.USD","LU1366333091.USD","2NVD.UK","NVDQ","IE0034235303.USD","LU0203201768.USD","LU0096362180.USD","BK4593","LU2023250330.USD","LU0353189680.USD","LU0957808578.USD","LU1721428933.USD","LU2360107168.USD","04335","LU0320765059.SGD","LU0957791311.USD","LU0823434583.USD","LU1814569148.SGD","BK4099","BK4503","LU0080751232.USD","LU1496350171.SGD","LU2065169927.USD","LU2236285917.USD","LU0210536198.USD","AALG","BK4529","BK4554","SG9999000418.SGD","SG9999015945.SGD","NVDU","LU1400636491.USD","LU2077746001.SGD","IE00BQXX3F31.USD","LU1914381329.SGD","HOOD","BK4605","LU0683600562.USD","LU0348723411.USD","LU1839390173.USD","LU2322448957.HKD","LU2473716301.USD","LU2505996681.GBP","LU0786609619.USD","LU2063271972.USD","SG9999013460.SGD","LU0215105999.USD","LU2213496289.HKD","LU0211327993.USD","SG9999006266.SGD","LU2462591350.SGD","LU0029864427.USD","LU0109391861.USD","LU2168564065.EUR","LU2420271590.USD","LU1720051017.SGD","BK4534","LU0321505439.SGD","BK4511","LU2023250504.SGD","SG9999002406.SGD","BK4532","LU0345770308.USD","LU2746668461.USD","IE000ITXATA3.USD","HOOI","SG9999014906.USD","LU2125909247.SGD","SGXZ81514606.USD","LU0640476718.USD","LU0251132253.USD","LU1935042215.USD","SG9999013486.USD","LU1232071149.USD","TSLG","LU1280957306.USD","LU2462591277.SGD","LU0868494617.USD","IE0004445015.USD","LU2430703095.HKD","LU0708995401.HKD","LU0267386448.USD","IE00BD6J9T35.USD","LU0056508442.USD","HODU","LU2361044865.SGD","IE00BKPKM429.USD","IE00BQXX3C00.GBP","TSLQ","LU1868837300.USD","LU1400636574.HKD","LU0187121727.USD","LU1674673428.USD","TESL","LU1116320737.USD","LU0109392836.USD","QQQ","SGXZ51526630.SGD","BK4602","LU0889565833.HKD","LU1066051225.USD","BK4512","LU2191332357.HKD","LU0265550359.USD","LU2097344431.USD","BK4551","LU0965509101.SGD","LU2750360997.AUD","BK4598","LU2381873111.SGD","LU0256863902.USD","LU1804176565.USD","SG9999001424.SGD","BK4022","TSLP","ALLO","LU0444971666.USD","LU2244417387.USD","LU2491050154.USD","NVDL","LU2433249047.HKD","LU2954938101.SGD","LU2417539215.USD","PLTR","LU2087621335.USD","LU0265550946.USD","LU0354030438.USD","LU1066051811.HKD","BK4588","LU1261432733.SGD","LU2237438978.USD","LU1935042488.USD","LU0511384066.AUD","IE00BJTD4V19.USD","LU2272731865.HKD","IE00BJLML261.HKD","HOYY","LU2294711713.HKD","LU2271345857.HKD","LU1066053197.SGD","LU2264538146.SGD","LU0158827948.USD","SGXZ99366536.SGD","SG9999014575.USD","IE0001KFT4U8.USD","IE00B1BXHZ80.USD","LU0097036916.USD","LU1988902786.USD","LU0061474960.USD","LU0203202063.USD","SG9999013478.USD","LU2360032135.SGD","IE00BMPRXQ63.HKD","LU0532188223.SGD","NVDO","BMNG","LU2054465674.USD","IE00BN29S564.USD","LU2471134796.USD","BK4555","LU2242650005.HKD","BK4122","BK4543","LU1496350502.SGD","LU0175139822.USD","LU2290526834.HKD","LU2471134952.CNY","LU0170899867.USD","LU2462157665.USD","BK4141","LU2125154778.USD","NVDW","LU2357305700.SGD","LU1815333072.USD","LU2083900584.USD","LU0689626769.HKD","SG9999014559.SGD","SGXZ31699556.SGD","LU0143551892.USD","LU1852331112.SGD","LU2065170008.USD","LU1791710400.SGD","LU0347712357.USD","PLTD","CRSH","SG9999004303.SGD","LU2065171311.SGD","LU0965509283.SGD","LU1084165304.USD","HK0000532082.HKD","LU2860962120.EUR","IE0003U64NQ7.SGD","LU1868837136.USD","LU2361044949.HKD","LU2756315318.SGD","LU1435385759.SGD","LU2357125470.USD","LU0198837287.USD","LU0823421333.USD","LU2362541273.HKD","LU2326559502.SGD","NVDA","IE000W1ABFV2.USD","LU1642822529.SGD","LU0882574139.USD","LU0107464264.USD","LU2592432038.USD","BK4612","LU2491049909.HKD","ANV","LU1935042991.SGD","TSLW","IE00BK4W5M84.HKD","TSLI","LU0070217475.USD","LU0345769631.USD","LU2148611432.USD","LU2065171402.SGD","LU0861579265.USD","BK4614","LU1691799644.USD","LU0353189763.USD","LU1861558580.USD","SG9999014542.SGD","LU0094547139.USD","LU0308772762.SGD","LU1712237335.SGD","IE0004445239.USD","SG9999002620.SGD","NVDG","LU1992135399.USD","LU0057025933.USD","NVDD","QQQI","BK4548","HK0000819398.USD","GB00BDT5M118.USD","BK4561","LU2087625088.SGD","IE00B4YYXB79.USD","SG9999002414.USD","LU0964807845.USD","HK0000306685.HKD","LU0354030511.USD","IE00B5949003.HKD","BIRD","LU1400636657.SGD","LU0106261372.USD","LU0256863811.USD","LU2111349929.HKD","BK4549","LU0466842654.USD","LU2168564149.EUR","LU0053666078.USD","LU2756315664.SGD","TSLR","LU1720051108.HKD","LU0441851309.USD","SG9999015978.USD","HK0000320264.USD","SG9999017495.SGD","IE00B7KXQ091.USD","LU1934455277.USD","IE0034235295.USD","IE00BK4W5L77.USD","BK4574","LU2931357623.SGD","LU1366192091.USD","LU1989764664.SGD","LU0158827781.USD","LU1066051498.USD","LU0689472784.USD","IE00BYXW3230.USD","LU1244550577.SGD","LU2552382132.HKD","SG9999018865.SGD","IE00BHPRN162.USD",".IXIC","LU0823411888.USD","LU0154236417.USD","LU1064131342.USD","LU2322448791.USD","SGXZ58947870.SGD","TSLL","LU0345770993.USD","NVII","IMMP","LU0719512351.SGD","LU1791710582.SGD","LU2458330243.SGD","HOOY","LU1244550221.USD","LU1868836914.USD","LU2237957902.USD","LU0476273544.USD","HOII","BMNR","LU1934455863.HKD","LU2089985449.USD","LU2089283258.USD","TEST","BK4539","LU3102509885.SGD","LU0128525929.USD","LU1670756490.USD","TQQQ","IE00B3SWFQ91.USD","LU1839511570.USD","LU2272731600.USD","LU2089284900.SGD","LU1935043023.USD","AAL","IE000M9KFDE8.USD","LU0174119429.USD","IE0009G5SDU7.USD","LU1868836757.USD","LU0072462426.USD","LU1429558221.USD","07766","SOFI","LU2097344357.USD","BK4127","SG9999014914.USD","LIMN","LU1633808545.USD","TSLO","LU1935043536.SGD","IE00BKDWB100.SGD","IE00BJJMRX11.SGD","IE00BZ199S13.USD","TSLS","IE00BKVL7J92.USD","LU2896262040.SGD","LU2023251221.USD","LU2045819591.USD","LU2125909593.SGD","IE00B1XK9C88.USD","LU0868494708.USD","LU0390134368.USD","LU0211328371.USD","IE00BZ1G4Q59.USD","LU2125909916.SGD","LU0225283273.USD","BK4604","BK4581","LU2413666699.HKD","IE00B775SV38.USD","BK4608","LU2413666426.HKD","HK0000304805.HKD","HK0000914660.USD","SG9999015986.USD","LU0210533765.USD","IE00BMPRXR70.SGD","LU1861220033.SGD","HOOZ","LU1267930490.SGD","LU0011850046.USD","TSLY","SG9999014880.SGD","LU2461242641.AUD","IE00BMPRXN33.USD","LU0820562030.AUD","LU1674673691.USD","LU1917777945.USD","LU1868836591.USD","LU1699723380.USD","LU2471134523.USD","TLA","LU2125910500.SGD","SG9999002604.SGD","LU0276348264.USD","IE00BDCRKT87.USD","LU0823414551.USD","LU0289739343.SGD","HK0000304797.USD","LU2456880835.USD","LU0985320562.USD","LU1116320901.HKD","LU0234572021.USD","LU0289961442.SGD","LU0820561909.HKD","LU1037948897.HKD","LU1571399168.USD","LU2505996509.AUD","BK4550","LU0444973449.USD","LU0942090050.USD","BK4547","LU0472753341.HKD","LU2463028550.USD","BK4527","LU2272731782.SGD","LU0321505868.SGD","LU1629891620.HKD","BK4516","IE00BSNM7G36.USD","LU2430703251.USD","LU2487616109.SGD","LU1037948541.HKD","LU2403377893.USD","LU0238689110.USD","LU2552382215.SGD","NVD","LU2211815571.USD","LU0079474960.USD","LU0310800379.SGD","LU2247934214.USD","IE0004086264.USD","TSDD","IE00B19Z9505.USD","LU0965509010.AUD","TSYY","LU0069063385.USD","LU1992135472.HKD","LU0096364046.USD","LU0316494557.USD","LU1244550494.USD","SG9999002224.SGD","LU1119994496.HKD","LU1645745479.HKD","LU0289960550.SGD","IE00BFSS7M15.SGD","LU0006306889.USD","LU0724617625.USD","LU1951198990.SGD","LU1821325948.USD","SGXZ23171101.USD","LU0823434740.USD","IE00B3M56506.USD","LU1861127337.USD","LU2242649171.HKD","IE00BJJMRY28.SGD","LU2106854487.HKD","LU0823421416.USD","TSLZ","3NVD.UK","LU2471134879.HKD","HK0000320223.HKD","LU2458330169.SGD","LU1815336760.USD","SG9999015341.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624553495","title":"Liminatus Pharma FY25 net loss widens to $10.2 million; operating loss narrows to $3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624553495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624553495?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:31","pubTimestamp":1774992668,"startTime":"0","endTime":"0","summary":"Liminatus Pharma posted a net loss of $10.2 million for fiscal 2025.General and administrative expense climbed to $3 million, driven by higher accounting and legal costs tied to the business combination and operating as a public company.Management flagged substantial doubt about its ability to continue as a going concern, planning to raise additional cash through equity or debt financings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL3yt0PX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620424361","title":"Liminatus Pharma plans Phase 1 trial of CD47 antibody IBA101 in lung cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2620424361","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620424361?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:08","pubTimestamp":1773749309,"startTime":"0","endTime":"0","summary":"Liminatus Pharma announced plans to initiate a Phase 1 clinical trial of IBA101, a CD47-blocking monoclonal antibody. The study is designed to start with monotherapy dose escalation assessing safety, tolerability, and pharmacokinetics, followed by combination cohorts with PD-1/PD-L1 therapies within the same protocol. Lung cancer is the initial focus for the Phase 1 program. The trial is planned to be led by Se-Hoon Lee and will include translational analyses of immune activity and biological features associated with clinical benefit. No clinical results have been presented, and none were stated as scheduled for future presentation.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLpJLjN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014021.USD","BK4112","IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014005.SGD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4585","BK4588","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014039.USD","BK4139","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620424358","title":"Liminatus Pharma Announces Planned Phase 1 Clinical Trial of Iba101, a Next-Generation Cd47 Blocking Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2620424358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620424358?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:08","pubTimestamp":1773749280,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUABT7J4H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617556946","title":"Liminatus Pharma Cuts Shareholder Meeting Quorum to One-Third","url":"https://stock-news.laohu8.com/highlight/detail?id=2617556946","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617556946?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:17","pubTimestamp":1772659067,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc.’s board approved an amendment to the company’s bylaws lowering the stockholder meeting quorum requirement from a majority to one-third of the voting power of outstanding shares entitled to vote. The change took effect immediately and will be submitted for stockholder ratification at the next annual meeting, though the board may keep the amendment even if stockholders do not approve it under Delaware law.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 04, 2026, and is solely responsible for th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL7mdvV6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1329},{"period":"1month","weight":-0.3063},{"period":"3month","weight":-0.3876},{"period":"6month","weight":-0.8305},{"period":"1year","weight":-0.9942},{"period":"ytd","weight":-0.7669}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Iris Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. The company was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp is a subsidiary of Iris Acquisition Holdings LLC.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.012085},{"month":2,"riseRate":0.8,"avgChangeRate":-0.095795},{"month":3,"riseRate":0.4,"avgChangeRate":-0.116654},{"month":4,"riseRate":0.6,"avgChangeRate":-0.021172},{"month":5,"riseRate":0.2,"avgChangeRate":-0.040756},{"month":6,"riseRate":0.5,"avgChangeRate":0.148546},{"month":7,"riseRate":0.4,"avgChangeRate":-0.094814},{"month":8,"riseRate":0.2,"avgChangeRate":-0.116647},{"month":9,"riseRate":0.6,"avgChangeRate":-0.070493},{"month":10,"riseRate":0.6,"avgChangeRate":-0.032984},{"month":11,"riseRate":0.4,"avgChangeRate":-0.052841},{"month":12,"riseRate":0.6,"avgChangeRate":-0.075377}],"exchange":"NASDAQ","name":"Liminatus Pharma LLC","nameEN":"Liminatus Pharma LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liminatus Pharma LLC(LIMN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liminatus Pharma LLC(LIMN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liminatus Pharma LLC,LIMN,Liminatus Pharma LLC股票,Liminatus Pharma LLC股票老虎,Liminatus Pharma LLC股票老虎国际,Liminatus Pharma LLC行情,Liminatus Pharma LLC股票行情,Liminatus Pharma LLC股价,Liminatus Pharma LLC股市,Liminatus Pharma LLC股票价格,Liminatus Pharma LLC股票交易,Liminatus Pharma LLC股票购买,Liminatus Pharma LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liminatus Pharma LLC(LIMN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liminatus Pharma LLC(LIMN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction